Selection Criteria for Lung-Cancer Screening
Martin C. Tammemägi(Brock University), Christine D. Berg(Prevention Group), John Commins(National Institutes of Health), Neil E. Caporaso(Unknown), Anil K. Chaturvedi(National Cancer Institute), Paul A. Kvale(Henry Ford Health System), Gerard A. Silvestri(MUSC Hollings Cancer Center), Tom Riley(National Institutes of Health), William G. Hocking(Marshfield Clinic), Timothy R. Church(University of Minnesota), Hormuzd A. Katki(Cancer Genetics (United States))
Cited by 1,008
Related Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
|Journal of Clinical Oncology|2008|1.6k
Methods for Staging Non-small Cell Lung Cancer
|CHEST Journal|2013|1.5k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k